Van den Bosch F - Search Results

1

Clinical assessment in the spondyloarthropathies, including psoriatic arthritis.

Van den Bosch F, Cryssen BV, Mielants H. Van den Bosch F, et al. Curr Opin Rheumatol. 2006 Jul;18(4):354-8. doi: 10.1097/01.bor.0000231902.27419.64. Curr Opin Rheumatol. 2006. PMID: 16763454 Review.

2

Bone scintigraphy of the hands in early stage lupus erythematosus and rheumatoid arthritis.

Van de Wiele C, Van den Bosch F, Mielants H, Simons M, Veys EM, Dierckx RA. Van de Wiele C, et al. Among authors: van den bosch f. J Rheumatol. 1997 Oct;24(10):1916-21. J Rheumatol. 1997. PMID: 9330932

3

Enrichment of T cells carrying beta7 integrins in inflamed synovial tissue from patients with early spondyloarthropathy, compared to rheumatoid arthritis.

Elewaut D, De Keyser F, Van Den Bosch F, Lazarovits AI, De Vos M, Cuvelier C, Verbruggen G, Mielants H, Veys EM. Elewaut D, et al. Among authors: van den bosch f. J Rheumatol. 1998 Oct;25(10):1932-7. J Rheumatol. 1998. PMID: 9779846

4

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study.

Van den Bosch F, Kruithof E, Baeten D, De Keyser F, Mielants H, Veys EM. Van den Bosch F, et al. Ann Rheum Dis. 2000 Jun;59(6):428-33. doi: 10.1136/ard.59.6.428. Ann Rheum Dis. 2000. PMID: 10834859 Free PMC article.

5

Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity.

Baeten D, Demetter P, Cuvelier C, Van Den Bosch F, Kruithof E, Van Damme N, Verbruggen G, Mielants H, Veys EM, De Keyser F. Baeten D, et al. Among authors: van damme n, van den bosch f. Ann Rheum Dis. 2000 Dec;59(12):945-53. doi: 10.1136/ard.59.12.945. Ann Rheum Dis. 2000. PMID: 11087697 Free PMC article.

6

Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms.

Van den Bosch F, Kruithof E, De Vos M, De Keyser F, Mielants H. Van den Bosch F, et al. Lancet. 2000 Nov 25;356(9244):1821-2. doi: 10.1016/s0140-6736(00)03239-6. Lancet. 2000. PMID: 11117919 Clinical Trial.

7

Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study.

Baeten D, Kruithof E, Van den Bosch F, Demetter P, Van Damme N, Cuvelier C, De Vos M, Mielants H, Veys EM, De Keyser F. Baeten D, et al. Among authors: van damme n, van den bosch f. Arthritis Rheum. 2001 Jan;44(1):186-95. doi: 10.1002/1529-0131(200101)44:1<186::AID-ANR25>3.0.CO;2-B. Arthritis Rheum. 2001. PMID: 11212159 Free article.

8

Characteristic marco- and microscopic aspect of the synovial membrane in crystal induced arthritis.

van den Bosch F, Baeten D, Kruithof E, de Keyser F, Veys EM. van den Bosch F, et al. J Rheumatol. 2001 Feb;28(2):392-3. J Rheumatol. 2001. PMID: 11246686 No abstract available.

9

Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha.

Baeten D, Van Damme N, Van den Bosch F, Kruithof E, De Vos M, Mielants H, Veys EM, De Keyser F. Baeten D, et al. Among authors: van damme n, van den bosch f. Ann Rheum Dis. 2001 Aug;60(8):750-5. doi: 10.1136/ard.60.8.750. Ann Rheum Dis. 2001. PMID: 11454638 Free PMC article.

10

Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up.

Kruithof E, Van den Bosch F, Baeten D, Herssens A, De Keyser F, Mielants H, Veys EM. Kruithof E, et al. Among authors: van den bosch f. Ann Rheum Dis. 2002 Mar;61(3):207-12. doi: 10.1136/ard.61.3.207. Ann Rheum Dis. 2002. PMID: 11830424 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

353 results

Search Page